BFEC
FBIO icon

Benjamin F. Edwards & Company’s Fortress Biotech FBIO Stock Holding History

Benjamin F. Edwards & Company’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-50
Closed -$2K – 1178
2015
Q3 		$2K Hold
50
– – ﹤0.01% 1064
2015
Q2 		$3K Buy
+50
New +$2.57K ﹤0.01% 1075

Other funds holding FBIO

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

Benjamin F. Edwards & Company's FBIO Position: Q4 2015 in Review

Benjamin F. Edwards & Company sold out of Fortress Biotech (FBIO) in Q4 2015, closing a stake of 50 shares — an estimated $2K sold.

Benjamin F. Edwards & Company first reported a position in FBIO in Q2 2015 and held it in 2 quarters. The position peaked at $3K in Q2 2015. 40 funds tracked by Wall St. Rank hold FBIO as of Q4 2015.

  • Benjamin F. Edwards & Company reported no remaining Fortress Biotech position as of Q4 2015 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 50 Fortress Biotech shares in Q4 2015, an estimated $2K.
  • Benjamin F. Edwards & Company first reported a position in Fortress Biotech in Q2 2015 and held it in 2 quarters.
  • Benjamin F. Edwards & Company's Fortress Biotech position peaked at $3K in Q2 2015.
  • 40 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2015.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2015, filed 12 Jan 2016.